News

Flamel Technologies is engaged in 17 partnered projects and is working with seven of the top-twenty pharmaceutical companies in the world, including a continuing research collaboration with Pfizer.

Since 1998, Mr Lerman has served as a litigation partner at Winston & Strawn in Chicago, where he concentrated his practice in white-collar defense, product liability and securities

Vasovist is the first contrast agent approved for marketing in the US for use with MRA, a non-invasive modality for imaging blood vessels, the company said. Vasovist had

Abstral is a rapid dissolving, sub-lingual tablet of fentanyl, indicated for the management of breakthrough cancer pain in patients who are already receiving opioid analgesics. Abstral is currently

This tranche was dominated by a new investment from Baxter International to go along with the September 2008 investments by new investors Genzyme Ventures and Mitsubishi UFJ Capital.

The CG100649 treatment group met the primary efficacy endpoint by demonstrating a clinically and statistically significant change in the WOMAC osteoarthritis (OA) score from baseline to day 21

Aplenzin, which was approved by the FDA in April 2008, is indicated for the treatment of major depressive disorder. Biovail anticipates that Sanofi Aventis US will launch the

In Phase III studies Firmagon (degarelix) produced a significant reduction in levels of testosterone within three days in more than 96% of study patients. Testosterone plays a major

From 2005 to 2008, Mr Bowen was vice president and CFO for GSI Group. At GSI Group, Mr Bowen led the consolidation of the company’s financial operations, implemented